Pharmaceuticals UAE

UAE HPV Vaccines Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

UAE HPV Vaccines Market Industry Trends and Forecast to 2034: Segmented by (Type, Gender, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

UAE · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $55.0 Mn Placeholder estimate
Estimate 2025 $60.0 Mn 0.5% of the global market
Projected 2034 $131.4 Mn 119% Adds $71.4 Mn over 9 forecast years
CAGR 2025–2034 9.1% Faster than 52% of 180 Pharmaceuticals markets here
Key players 5
  • UAE is 0.54% of the global market.
  • In Middle East, the largest is Saudi Arabia at $195.1 Mn.
  • Fastest growing: Saudi Arabia at 9.2% a year.
  • UAE ranks 2nd of 2 by size in Middle East.

Market size projection

UAE

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$71.4 Mn total, 2026–2034

Year-by-year market size, 2024–2034
HPV Vaccines Market market size by year, UAE
YearMarket sizeChange that yearSince 2025
2024 (estimate) $55.0 Mn — —
2025 (base) $60.0 Mn +$5.0 Mn —
2026 (forecast) $65.4 Mn +$5.5 Mn +9.1%
2027 (forecast) $71.4 Mn +$6.0 Mn +19%
2028 (forecast) $77.9 Mn +$6.5 Mn +29.9%
2029 (forecast) $85.0 Mn +$7.1 Mn +41.7%
2030 (forecast) $92.7 Mn +$7.7 Mn +54.6%
2031 (forecast) $101.2 Mn +$8.4 Mn +68.6%
2032 (forecast) $110.4 Mn +$9.2 Mn +84%
2033 (forecast) $120.4 Mn +$10.0 Mn +100.7%
2034 (forecast) $131.4 Mn +$11.0 Mn +119%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $11.08 Bn
  2. North America $6.25 Bn
  3. US $4.47 Bn
  4. APAC $2.23 Bn
  5. Europe $1.77 Bn
  6. Canada $829.7 Mn
  7. China $842.9 Mn
  8. Japan $771.5 Mn
  9. Latin America $443.9 Mn
  10. Middle East $397.6 Mn
  11. Germany $368.3 Mn
  12. UK $300.0 Mn
  13. Italy $284.9 Mn
  14. France $276.5 Mn
  15. Brazil $271.6 Mn
  16. Ecuador $246.0 Mn
  17. Spain $238.8 Mn
  18. India $233.1 Mn
  19. Saudi Arabia $195.1 Mn
  20. Africa $182.3 Mn
  21. Mexico $159.6 Mn
  22. Australia $136.8 Mn
  23. New Zealand $110.3 Mn
  24. Russia $108.2 Mn
  25. South Africa $65.3 Mn
  26. UAE (this report) $60.0 Mn
  27. Egypt $27.7 Mn
  28. Philippines $25.9 Mn
  29. Malaysia $20.6 Mn
  30. Hong Kong $20.2 Mn
  31. Singapore $13.6 Mn
  32. Thailand $12.7 Mn
  33. Kenya $7.1 Mn

Report snapshot

UAE HPV Vaccines Market Analysis at a glance
Market size, 2025$60.0 Mn placeholder estimate
Forecast, 2034$131.4 Mn placeholder estimate
Growth (CAGR), 2025–20349.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType, gender and end user (see all)
Key playersMerck & Co., Inc., GSK PLC, Serum Institute of India, Xiamen Innovax, Walvax Biotechnology (see all)
Regulator in the UAEEDESource: Emirates Drug Establishment. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The UAE HPV Vaccines Market Analysis Executive Summary

HPV vaccines protect against human papillomavirus types that cause cervical and other cancers and genital warts.

Key segments of the HPV Vaccines market include type (9-Valent, Bivalent and Quadrivalent) and gender (Female and Male).

Bar chart: UAE HPV Vaccines market size, 2024–2034, placeholder estimates. $55.0 Mn in 2024, $60.0 Mn in 2025 and $131.4 Mn in 2034, 9.1% CAGR.
UAE HPV Vaccines market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

UAE HPV Vaccines Market Dynamics

Market Growth Drivers

Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the HPV Vaccines market.

Opportunity

New vaccines, rapid tests and public-private funding for neglected diseases give the HPV Vaccines market room to grow, especially in Asia, Africa and Latin America.

Market Restraints

Low prices in poorer markets, weak returns for new antibiotics, vaccine hesitancy and cold-chain problems hold back the HPV Vaccines market.

Competitive Landscape for HPV Vaccines Market in UAE

The HPV Vaccines market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for HPV Vaccines Market in UAE

HPV Vaccines in the UAE: rules and payment

The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medicines from the Ministry of Health and Prevention.⁠[1] Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate.⁠[2]

[1] Emirates Drug Establishment. Checked 14 Nov 2026.

[2] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for HPV Vaccines. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in UAE.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in HPV Vaccines right now, from free public sources.

Latest research 1,087 papers since 2021 (worldwide)

  1. Prevalence and distribution of high-risk human papillomavirus genotypes among women living with HIV in Nigeria. PloS one, 2026
  2. Therapeutic HPV16 E7 vaccination with CD137 agonism induces tumor regression and durable immunity in mice. iScience, 2026
  3. The role of human papillomavirus in the pathogenesis of oropharyngeal squamous cell carcinoma and the impact of vaccination on disease prevention: a narrative review. The Journal of laryngology and otology, 2026
  4. Rationale and design of randomized, double-blind trial evaluating the efficacy of single-dose HPV vaccine efficacy in women aged 18 to 30: The PRISMA trial. Vaccine, 2026
  5. Age-specific income losses due to HPV-attributable cancers in Singapore. PloS one, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

HPV Vaccines in context

The UAE compared

  • Health spending per person: 2,402 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 9 countries we cover in Middle East.[1]
  • Doctors: 2.99 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 3rd highest of the 9 countries we cover in Middle East.[2]
  • People aged 65 and over: 1.8% of people (2025). World: 10.4% of people (2025). 8th highest of the 9 countries we cover in Middle East.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the HPV Vaccines market in the UAE?
Placeholder estimate: about $60.0 Mn in 2025, rising to about $131.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the HPV Vaccines market in the UAE growing?
Placeholder estimate: about 9.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the HPV Vaccines market report cover?
The report splits the market by type (9-Valent, Bivalent, Quadrivalent), gender (Female, Male) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the HPV Vaccines market?
Key players include Merck & Co., Inc., GSK PLC, Serum Institute of India, Xiamen Innovax and Walvax Biotechnology.
What is driving the HPV Vaccines market?
Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the HPV Vaccines market.
Who regulates HPV Vaccines in the UAE?
The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medicines from the Ministry of Health and Prevention. Source: Emirates Drug Establishment. Checked 14 Nov 2026.
How is healthcare paid for in the UAE?
Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate. Source: Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
How much research is published on HPV Vaccines?
PubMed lists 1,087 papers on HPV Vaccines added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about HPV Vaccines in UAE? Our analysts can size it for your plan. Talk to us See the public data Measles vaccine for every country, free. Open the Public Health Dashboard

From our blog

Women's Health Supplements: A Growing FocusAnaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth… Brain Cancer Diagnosis: Imaging and New BiomarkersAbout 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died… Bioinformatics: Making Sense of Health DataSequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in UAE

See all
Same topic, other categories

Related on vaccines and women's health

See the topic